Mical Paul

Active 1997–2025

182
Papers
31,208
Citations
94
h-index
172
i10-index

Citations

Citations per year for Mical Paul1965: 2 citations1977: 1 citations1980: 1 citations1986: 1 citations1996: 1 citations1997: 1 citations1998: 2 citations1999: 3 citations2000: 4 citations2001: 4 citations2002: 4 citations2003: 7 citations2004: 11 citations2005: 25 citations2006: 33 citations2007: 55 citations2008: 69 citations2009: 67 citations2010: 96 citations2011: 148 citations2012: 140 citations2013: 171 citations2014: 182 citations2015: 159 citations2016: 168 citations2017: 208 citations2018: 250 citations2019: 992 citations2020: 1,190 citations2021: 1,296 citations2022: 1,220 citations2023: 1,001 citations2024: 1,684 citations2025: 731 citations2026: 12 citations1966–1976: no citations, so these years are not shown1978–1979: no citations, so these years are not shown1981–1985: no citations, so these years are not shown1987–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,406 citing papers, 16.3% of this breakdownChina: 1,283 citing papers, 8.7% of this breakdownUnited Kingdom: 1,003 citing papers, 6.8% of this breakdownItaly: 767 citing papers, 5.2% of this breakdownGermany: 656 citing papers, 4.5% of this breakdownSpain: 640 citing papers, 4.3% of this breakdownFrance: 618 citing papers, 4.2% of this breakdownAustralia: 525 citing papers, 3.6% of this breakdownCanada: 462 citing papers, 3.1% of this breakdownIndia: 388 citing papers, 2.6% of this breakdownSwitzerland: 371 citing papers, 2.5% of this breakdownNetherlands: 352 citing papers, 2.4% of this breakdown
0%16.3%Other 35.8%

Fields

  • Medicine40%
  • Biochemistry, Genetics and Molecular Biology37%
  • Immunology and Microbiology8.9%
  • Environmental Science3.9%
  • Agricultural and Biological Sciences3%
  • Health Professions1.3%
  • Other5.9%

Topics

  • Antibiotic Resistance in Bacteria12.8%
  • Antibiotics Pharmacokinetics and Efficacy5.4%
  • Antibiotic Use and Resistance5.3%
  • Bacterial Identification and Susceptibility Testing3.3%
  • Nosocomial Infections in ICU2.6%
  • Pneumonia and Respiratory Infections2.5%
  • Other68.1%

Coauthors

All papers

Open in search
  1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver J. Dyar, Alex W. Friedrich, Ana Cristina Gales, Sumanth Gandra, Christian G. Giske, Debra A. Goff, Herman Goossens, Thomas Gottlieb, Manuel Guzmán Blanco, Waleria Hryniewicz, Deepthi Kattula, Timothy Jinks, Souha S. Kanj, Lawrence D. Kerr, Marie-Paule Kiény, Yang Soo Kim, Roman S. Kozlov, Jaime Labarca, Ramanan Laxminarayan, Karin Leder, Leonard Leibovici, Gabriel Levy-Hara, Jasper Littman, Surbhi Malhotra‐Kumar, Vikas Manchanda, Lorenzo Moja, B Ndoye, Angelo Pan, David L. Paterson, Mical Paul, Haibo Qiu, Pilar Ramón-Pardo, Jesús Rodríguez‐Baño, Maurizio Sanguinetti, Sharmila Sengupta, Mike Sharland, Massinissa Si-Mehand, Lynn L. Silver, Wonkeung Song, Martin Steinbakk, Jens Thomsen, Guy Thwaites, J W van der Meer, Nguyễn Văn Kính, Silvio Vega, María Virginia Villegas, Agnes Wechsler-Fördös, Heiman Wertheim, Evelyn Wesangula, Neil Woodford, Fidan O Yilmaz, Anna Zorzet - The Lancet Infectious Diseases 2017 cited by 6,087

  2. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2021 cited by 995

  3. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

    Authors: , , , , , , , , , , , , , , , , , - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2019 cited by 931

  4. Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed

    Authors: , , , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2022 cited by 239

  5. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 cited by 624

  6. Critical analysis of antibacterial agents in clinical development

    Authors: , , , , , , - Nature Reviews Microbiology 2020 cited by 372

  7. Comparison of antibiotic-resistant bacteria and antibiotic resistance genes abundance in hospital and community wastewater: A systematic review

    Authors: , , , , , , , , , - The Science of The Total Environment 2020 cited by 290

  8. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naomi Runnegar, David Andresen, Nicholas Anagnostou, Sandra Johnson, Mark D. Chatfield, Allen Cheng, Vance G. Fowler, Benjamin P. Howden, Niamh Meagher, David J. Price, Sebastiaan J. van Hal, Matthew O’Sullivan, Joshua S. Davis - JAMA 2020 cited by 275

  9. Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason M. Pogue - NEJM Evidence 2022 cited by 143

  10. Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2018 cited by 412

  11. Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase–Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies

    Authors: , , , , , , - Clinical Infectious Diseases 2022 cited by 105

  12. Corticosteroids for pneumonia

    Authors: , , , , , - Cochrane Database of Systematic Reviews 2017 cited by 272

  13. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Höger, Xiaoyun Hu, Quazi Tarikul Islam, Mirela Foresti Jiménez, Amr Kandeel, Gerben Keijzers, Hossein Khalili, Marian Knight, Koichiro Kudo, Gabriela Kusznierz, Ilija Kuzman, Arthur Ming‐Chit Kwan, Idriss Lahlou Amine, Eduard Langenegger, Kamran Bagheri Lankarani, Yee‐Sin Leo, Rita Linko, Pei Liu, Faris Madanat, Elga Mayo-Montero, Allison McGeer, Ziad A. Memish, Gökhan Metan, Auksė Mickienė, Dragan Mikić, Kristin G. I. Mohn, Ahmadreza Moradi, Pagbajabyn Nymadawa, Maria E. Oliva, Mehpare Özkan, Dhruv Parekh, Mical Paul, Fernando P. Polack, Barbara A. Rath, Alejandro Rodríguez, Elena Beatriz Sarrouf, Anna C. Seale, Bünyamin Sertoğullarından, Marilda Mendonça Siqueira, Joanna Skręt‐Magierło, Stephan Frank, Ewa Talarek, Julian W. Tang, Kelvin Kai‐Wang To, Antoni Torres, Selda Hançerlı Törün, Dat Tran, Timothy M. Uyeki, Annelies van Zwol, Wendy Vaudry, Tjasa Vidmar, Renata T C Yokota, Paul Zarogoulidis, Jonathan S. Nguyen‐Van‐Tam - The Lancet Respiratory Medicine 2014 cited by 648

  14. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients

    Authors: , , , , - Cochrane Database of Systematic Reviews 2014 cited by 451

  15. Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

    Authors: , , , , , - Antimicrobial Agents and Chemotherapy 2010 cited by 724

  16. Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , - Clinical Microbiology and Infection 2021 cited by 104

  17. Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2024 cited by 102

  18. Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis

    Authors: , , , , , , , , - Trials 2022 cited by 119

  19. TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old Foe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emma Best, Max Bloomfield, Jennifer Bostock, Carly L. Botheras, Asha C Bowen, Philip N Britton, Hannah J. Burden, Anita J Campbell, Hannah Carter, Matthew P. Cheng, Ka Lip Chew, Russel Lee Ming Chong, Geoffrey W. Coombs, Peter Daley, Nick Daneman, Jane C. Davies, Joshua S. Davis, Yael Dishon, Ravindra Dotel, Adrian Dunlop, Felicity Flack, Katie L. Flanagan, Hong Foo, Nesrin Ghanem‐Zoubi, Stefano Giulieri, Anna L. Goodman, Jennifer Grant, Dan Gregson, Stephen Guy, Amanda Gwee, Erica Hardy, Andrew Henderson, George Heriot, Benjamin P. Howden, Fleur Hudson, Jennie Johnstone, Shirin Kalimuddin, Dana de Kretser, Andrea Lay‐Hoon Kwa, Todd A. Lee, Amy Legg, Roger Lewis, Martin Llewelyn, Thomas Lumley, David Chien Lye, Derek R. MacFadden, Robert K. Mahar, Isabelle Malhamé, Michael Marks, Julie Marsh, Marianne Martinello, Gail Matthews, Colin McArthur, Anna McGlothlin, Genevieve McKew, Brendan McMullan, Zoe McQuilten, Eliza Milliken, Jocelyn Mora, Susan C. Morpeth, Srinivas Murthy, Clare Nourse, Matthew O’Sullivan, David L. Paterson, Mical Paul, Neta Petersiel, Lina Petrella, Sarah Pett, David J. Price, Jason Roberts and 27 more - Clinical Infectious Diseases 2022 cited by 101

  20. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals

    Authors: , , , , , - Microbial Pathogenesis 2012 cited by 426

  21. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis

    Authors: , , , , , - PLoS ONE 2015 cited by 294

  22. Analysis of the clinical antibacterial and antituberculosis pipeline

    Authors: , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 cited by 219

  23. Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nizar Andria, Ami Neuberger, Anat Stern, Neta Petersiel, Marina Raines, Amir Karban, Leonard Leibovici, Dafna Yahav, Noa Eliakim‐Raz, Oren Zusman, Michal Elbaz, Heyam Atamna, Vered Daitch, Tanya Babich, Yehuda Carmeli, Amir Nutman, Amos Adler, Inbar Levi, George L. Daikos, Anna Skiada, Ioannis Pavleas, Anastasia Antoniadou, Antigoni Kotsaki, Emanuele Durante‐Mangoni, Roberto Andini, Domenico Iossa, Mariano Bernardo, Giusi Cavezza, Lorenzo Bertolino, Giuseppe Giuffrè, Roberto Giurazza, Susanna Cuccurullo, Maria Galdo, Patrizia Murino, Adriano Cristinziano, Antonio Corcione, Rosa Zampino, Pia Clara Pafundi - Clinical Infectious Diseases 2018 cited by 126

  24. Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gilat Livni, Mical Paul, Menachem Gross, Matityahou Ormianer, Saima Aslam, Michele Ritter, Kenneth L. Urish, Ricardo M. La Hoz, Ameneh Khatami, Philip N Britton, Ruby C.Y. Lin, Jonathan R. Iredell, Aleksandra Petrović Fabijan, Stephanie Lynch, Pranita D. Tamma, Alexandra Yamshchikov, Emil Lesho, Megan M Morales, Alissa Werzen, Kapil Saharia - Med 2023 cited by 53